KPMG tech innovator Radicle Science bridges supplement industry’s proof gap – press release

SAN DIEGO, CA - Radicle Science, the first-and-only AI-driven healthtech B-corp offering the first easy path for health and wellness products to clinically prove their true effects beyond placebo, makes its debut to the supplement industry at SupplySide West. Radicle was named by KPMG as one of America's Top 10 "Tech Innovators" out of thousands of companies evaluated for having "developed innovative, proven technologies, established robust business models, demonstrated traction and exhibited the potential to become a 'future tech titan.” By generating first-of-its kind clinical evidence across diverse conditions and populations, all at unprecedented affordability, speed and scale, Radicle Science addresses the Proof Gap between non-prescription consumer health products and pharmaceutical drugs, as, until now, proof was largely out of reach for non-pharmaceuticals and the consumers they serve. Come by Booth #7433 at SupplySide West to participate in a health and wellness experience and find out what it's like to volunteer for a Radicle Science clinical trial.

The Problem: Lack of Clinical Proof

The vast majority of supplement brands don't have clinical proof of their products’ effectiveness because they can’t easily access clinical trials. Natural products, such as nutraceuticals and dietary supplements, can’t be patented and thus have largely been ignored by pharma and modern healthcare. Unlike patented medical treatments, these “democratized” products can’t afford the expense and long duration of traditional clinical trials. This has led to the paradoxical situation where Americans spend ten times more on pharmaceuticals ($600B/year) than supplements ($60B/year) even though more Americans take supplements than pharmaceuticals! In fact, today more than 80% of Americans use natural products like nutraceuticals and dietary supplements. The disparity of these numbers underscores key differentials: pharmaceuticals are expensive yet patented and proven and have gatekeepers, while most supplement brands are unpatented and unproven, but inexpensive and accessible by all.

“Due to lack of easy access to clinical trials, nutraceuticals have been largely relegated to relying on testimonials and fancy advertising to sway consumers, drive sales and differentiate themselves in a crowded market,” says Pelin Thorogood, Radicle Science Co-Founder and Executive Chair. “That’s why the best selling supplement products often are the ones with the most money spent on marketing–not on generating proof that they work. But it doesn’t have to be this way, and with our transformative approach to clinical trials, it won’t.”

The Radicle Science Solution

The Proof Gap has persisted over decades and continues to cause immeasurable damage—needlessly limiting the health of all humans…until now. Today, Radicle Science is at the perfect intersection of science and technology, establishing a new paradigm where:

“Radicle’s audacious mission has the potential to democratize clinical trials and unlock a future of abundant health products for all, “ said Peter Diamandis, Founder of the XPRIZE Foundation, named “50 Greatest World Leaders” by Fortune.

Proof Drives Transformation

For the first time in history, Radicle Science makes it easy and accessible to get proof on health and wellness products across the entire business lifecycle, from product development, to marketing, to customer retention:

“We’ve pioneered an AI-driven, crowdsourced, virtual, direct-to-consumer clinical trial approach that delivers rigorous health outcome data,” said Dr. Jeff Chen, Radicle Science CEO and Co-Founder. “We’ve made trials fast and affordable for the first time ever with standardization and automation. In essence, we’ve transformed clinical trials the same way that Ford Motors transformed auto manufacturing a century ago. We believe every non-pharmaceutical product should have easy access to a clinical trial, just like how every person should have easy access to transportation.”

History-Making Clinical Trials

After launching last year, the company conducted a multitude of history’s first and largest clinical trials on a variety of natural ingredients, studying 20,000 Americans across numerous health conditions. The results have given its clients everything from tens of millions of dollars of increased company valuation to triple digit increases in sales to winning over celebrity ambassadors who just needed to see proof before signing on.

Gaia Herbs, the NEXTY award-winning brand that set the gold standard for ethical transparency in the supplement industry, has partnered with Radicle Science to study the effectiveness of its products for stress and anxiety. Neurohacker, named by San Diego Business Journal as one of the top two health and wellness brands, is partnering with Radicle Science to research efficacy for cognition.

James Schmachtenberger, Co-Founder and CEO of Neurohacker said, “We are dedicated to research and development, including choosing our ingredients using the best data available. We are thrilled to take our research to the next level with Radicle Science’s disruptive clinical trials, which will provide invaluable data on optimal dosages and efficacy across all key demographics.”

About Radicle Science

Radicle Science is the first-and-only AI-driven healthtech B-corp offering history’s first easy path for non-pharmaceutical products to clinically prove their true effects beyond placebo. Radicle Science leverages a crowdsourced, virtual approach, enabling research across diverse populations and conditions at unprecedented affordability, speed and scale. The company’s Radicle vision is an abundant future where democratized access to clinical trials transforms non-pharmaceutical products into proven personalized medicines, accessible by all. To learn more about Radicle Science, visit www.RadicleScience.com.